Crohn's & Colitis Foundation of America
1
1
0.02
1
- Areas of investment
Summary
Crohn's & Colitis Foundation of America is the famous Corporate Investor, which was founded in 1967.
The high activity for fund was in 2018. The fund is generally included in less than 2 deals every year.
Among the various public portfolio startups of the fund, we may underline Vedanta Biosciences Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical, Business Development.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the Crohn's & Colitis Foundation of America, startups are often financed by Rock Springs Capital, PureTech Health, Invesco. In the next rounds fund is usually obtained by Partners Investment, Symbiosis Group, Symbiosis.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 1
- Rounds per year
- 0.02
- Investments by industry
- Business Development (1)
- Medical (1)
- Biotechnology (1)
- Drug Discovery (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.